PLOS ONE (journal)

Study highlights consequences of chronic benzodiazepine use

The lived experience of colleagues who took benzodiazepines and experienced distressing effects inspired a recent study that found the depressant is linked to nervous system injury and negative life effects during and after use.

Female health care workers more likely to leave profession during pandemic: HERO registry study

Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

Team members involved in the study include, from left, Melissa Hilmes, MD, Daniel Moore, MD, PhD, Alvin Powers, MD, Jon Williams, PhD, and Jack Virostko, PhD. (photo by Jessica Kimber)

Study proves standardized protocol can support reliable MRI use for multisite pancreatic research

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.

The study team includes, from left, Douglas Heimburger, MD, MS, Kondwelani Mateyo, MBChB, MMed, Justin Banerdt, MD, MPH, and E. Wesley Ely, MD.

Vanderbilt, Zambia researchers identify predictive factors of delirium in Sub-Saharan Africa

Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.

Vanderbilt, Zambia researchers find delirium in hospitalized patients linked to mortality, disability in Sub-Saharan Africa

Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE.

Imaging “biomarker” for Alzheimer’s disease progression

Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.

1 2 3 5